LAKE FOREST, Ill., Oct. 11, 2022 (GLOBE NEWSWIRE) — Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its third quarter 2022 earnings release and teleconference call.
| Earnings release: | Monday, November 7, 2022, after market close |
| Webcast and Teleconference: | Tuesday, November 8, 2022 at 8:30 a.m. EDT |
| Pactiv Evergreen Participants: | Michael King, CEO |
| Jon Baksht, CFO | |
| Dhaval Patel, SVP, Investor Relations & Corporate Strategy |
Participants may access the live webcast on the Company’s Investor Relations website at https://investors.pactivevergreen.com/news-events/events-presentations.
The call may also be accessed by dialing 1-877-300-9306 from the U.S. or 1-412-542-4176 internationally and using access code 10171979.
About Pactiv Evergreen Inc. Pactiv Evergreen Inc. (NASDAQ: PTVE) is a leading manufacturer and distributor of fresh foodservice and food merchandising products and fresh beverage cartons in North America. With a team of approximately 16,500 employees, the Company produces a broad range of on-trend and feature-rich products that protect, package and display food and beverages for today’s consumers. Its products, many of which are made with recycled, recyclable or renewable materials, are sold to a diversified mix of customers, including restaurants, foodservice distributors, retailers, food and beverage producers, packers and processors. Learn more at www.pactivevergreen.com.
Contact:
Dhaval Patel
732.501.9657
[email protected]
- Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging - September 15, 2024
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024 - September 15, 2024
- 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial - September 15, 2024
